Creatine Monohydrate

Name: Thorne Creatine Monohydrate
Brand: Thorne
Price: 32.00 USD
Availability: InStock

Best in ClassCreatine

The gold standard. NSF Certified for Sport, pure creatine monohydrate at the clinically validated 5g dose. No fillers, no nonsense.

94/ 100

Biorank Score

Independently ranked

94/ 100

Biorank Score

Independently ranked by Biorank Laboratories

Our Verdict

Best in Class

Thorne scores at the top because it combines the most evidence-backed form of creatine (monohydrate) with pharmaceutical-grade manufacturing, NSF Certified for Sport verification, and full label transparency. The 5g per serving matches the dose used in virtually all positive clinical trials. No proprietary blends, no unnecessary additions.

Key Findings

Uses Creapure -- the most tested creatine source globally
NSF Certified for Sport (banned substance tested)
5g dose matches clinical literature exactly
No fillers, flow agents, or artificial additives

Evidence Analysis

Creatine monohydrate is backed by over 500 peer-reviewed studies spanning 30+ years. It is the single most evidence-supported supplement for strength, power output, and lean mass gains. Meta-analyses consistently show 5-10% improvements in high-intensity exercise capacity. Thorne uses Creapure, the most tested form on the market, with third-party verification through NSF Certified for Sport.

Ingredient Breakdown

Ingredient	Dose	Effective Dose	Adequacy	Verdict
Creatine Monohydrate (Creapure)	5g	3-5g		Optimal

True Cost Analysis

Properly Dosed -- What You Pay Is What You Get

Listed Price

$0.36/serving

$10.80/month at 1 serving/day

True Cost Per Effective Dose

$0.36/effective dose

$10.80/month for effective dosing

Value Score

Excellent value

Save $8.40/month (78%)

by switching to BulkSupplements Creatine Monohydrate Powder

Where It Falls Short

Premium pricing compared to bulk creatine options. At $0.36/serving, you're paying roughly 3x what generic creatine monohydrate costs. The quality assurance justifies the premium for competitive athletes, but recreational users may find equivalent efficacy in lower-cost alternatives.